Organ support & nutrition

Long-term mortality after stage 1 acute kidney injury in critically ill patients - an observational cohort study

J Crit CarePublished Retrospective cohort study

Main finding · One-year mortalityResult — go to the resultOdds ratio 1.6 95 % CI 1.48–1.73

Authors' conclusion

Stage 1 AKI is associated with 1-year mortality in adult ICU patients even in steps below 26.5 μmol/L.

Study context

Population
Adult intensive care units (ICU) patients, two tertiary care centres in Switzerland and Austria (2013–2021)
Participants
42,446 patients
Exposure
Stage 1 Acute Kidney Injury (AKI) vs no AKI
  • Stage 1 AKIn = 4,667
  • Moderate/severe AKIn = 5,449
  • No AKIn = 32,330reference
Outcome
One-year mortality
Follow-up
One year
Methodological detailstwo tertiary care centres, multivariable regression, sensitivity analyses, Baseline creatinine determined using estimation formulas
  • Two tertiary care centres
  • Multivariable regression
  • Sensitivity analyses
  • Baseline creatinine determined using estimation formulas

Main finding

As reported in the abstract

Odds ratio

1.6

95 % CI 1.48–1.73

P < 0.001

Stage 1 AKI vs No AKI
OR 1.6 (95 % CI 1.48–1.73); P < 0.001

Observational data: associations, not effects.

Further findings

1-year mortality, patients with surgery (subgroup)

OR (95% CI)P value
With surgerySimilar association · subgroup analysis1.66 (1.45–1.89)P < 0.001

1-year mortality, patients without surgery (subgroup)

OR (95% CI)P value
Without surgerySimilar association · subgroup analysis1.61 (1.46–1.78)P < 0.001
Outcomeβ (95% CI)P value
ICU LOSStage 1 AKI vs No AKI · multivariable regression1.4 (1.2–1.5)P < 0.001
Hospital LOSStage 1 AKI vs No AKI · multivariable regression2.7 (2.1–3.2)P < 0.001

Original publication

Long-term mortality after stage 1 acute kidney injury in critically ill patients - an observational cohort study. J Crit Care. Published 29 May 2025. doi:10.1016/j.jcrc.2025.155130

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.